5 months UPDATE 2-Bristol Myers posts quarterly loss, revenue rises 5% Yahoo Finance UPDATE 2-Bristol Myers posts quarterly loss, revenue rises 5%. Bristol
5 hours Bristol-Myers Squibb’s Novel Schizophrenia Drug Wins FDA Approval; BMY Stock Signals BreakoutInvestor's Business Daily
1 day Bristol-Myers Squibb Company (BMY): Among the Dividend Giants with Lowest Short Interest in 2024Insider Monkey
1 week How Edgewise, Up 55%, Is Hoping To Edge Out Bristol, Cytokinetics In Heart DiseaseInvestor's Business Daily
2 weeks Drugmakers bet billions that targeted radiation could become the next cancer breakthroughCNBC
2 weeks Bristol Myers Squibb Company (BMY) Is a Trending Stock: Facts to Know Before Betting on ItZacks
3 weeks Bristol Myers Squibb: Momentum Still Promising Through H2 2024, Turnaround Likely ProlongedSeeking Alpha
3 weeks Bristol-Myers Squibb: Shares Getting Closer To The Tipping Point (Rating Downgrade)Seeking Alpha
3 weeks Bristol-Myers Squibb: A Better Earnings Outlook, Stronger Momentum Heading Into 2025Seeking Alpha
3 weeks Bristol-Myers Squibb Company (BMY) Wells Fargo 2024 Healthcare Conference (Transcript)Seeking Alpha
3 weeks Bristol Myers Squibb (BMY) Falls More Steeply Than Broader Market: What Investors Need to KnowZacks
3 weeks Is Bristol-Myers Squibb Company (BMY) The Best Beaten Down Dividend Stocks to Invest in Now?Insider Monkey
3 weeks Bristol-Myers Squibb Company (BMY) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)Seeking Alpha
4 weeks 2 Reasons Bristol Myers Squibb Stock Could Be a Bargain, Down 34% From Its All-Time HighThe Motley Fool
4 weeks How To Put $100 In Your Retirement Fund Each Month With Bristol-Myers Squibb StockYahoo Finance
2 months Largest U.K. stock broker accepts £5.4 billion bid from private equity consortium including CVCMarketWatch
2 months Bristol Myers Squibb Shows Resilience Amid Patent Expiry Challenges (Rating Upgrade)Seeking Alpha
2 months Bristol Myers Retakes Its 200-Day Line On Quarterly Beat, Surprise Immunology WinInvestor's Business Daily
2 months Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costsCNBC
2 months Novartis Dives After Handing Amgen, Bristol — And Their Rivals — A Key VictoryInvestor's Business Daily
3 months Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to KnowZacks
3 months 3 High-Yield S&P 500 Dividend Stocks Down More Than 25% to Buy Now and Hold for at Least a DecadeThe Motley Fool
4 months Bristol-Myers Squibb Company (BMY) Goldman Sachs 45th Annual Global Healthcare ConferenceSeeking Alpha
4 months Here’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)Insider Monkey
4 months Bristol-Myers Squibb Company (BMY) Bank of America Global Healthcare Conference 2024 TranscriptSeeking Alpha
5 months Cytokinetics Reverses Higher On ‘Pristine’ Results For Bristol Myers-Rivaling Heart DrugInvestor's Business Daily
5 months These Stocks Are Moving the Most Today: Tesla, Arm, Bristol Myers, GameStop, and MoreYahoo Finance
5 months Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?The Motley Fool
5 months If You’d Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here’s How Much You’d Have TodayThe Motley Fool
5 months The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas MedicineZacks
5 months Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion AcquisitionsYahoo Finance
5 months AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks DivergeInvestor's Business Daily
5 months Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly lossCNBC